Fluoride Retention in the Mouth of Older Adults
NCT04239872 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-01-31
Summary
Individuals with dry mouth (a reduction in the production of saliva) suffer from high rates of oral diseases. Dry mouth is a common problem among older individuals, because many medications to control chronic conditions (such as blood pressure, bladder-control problems and depression) reduce the flow of saliva. For these individuals, fluoride is used to maintain a good oral health. Usually, higher fluoride concentration products, such as prescription toothpastes, are recommended. In this project, the ability to increase fluoride retention in the mouth by using calcium before a conventional fluoride rinse will be tested in older adults with a range of salivary flow rates. This approach was never tested in patients with dry mouth, for whom the treatment with calcium may also be beneficial. A crossover, clinical study with two experimental phases will be conducted, in which patients with a range of saliva flows (from normal to dry mouth) will rinse with a fluoride rinse only (used at over the counter concentration), or a fluoride rinse preceded by a calcium rinse. The concentration of fluoride and calcium in the saliva and dental plaque residues will be determined up to two hours after the rinse(s), to test the effect of the approach to optimize fluoride retention in the mouth of patients with dry mouth.
Conditions
- Hyposalivation
Interventions
- DRUG
-
Fluoride mouthwash
Sodium fluoride, at a concentration of 0.05% (226 parts per million (ppm) of fluoride), will be used to rinse the mouth for 1 minute and expectorated.
- DRUG
-
Calcium and fluoride mouthwash
Calcium lactate, at a concentration of 150 milimolar, will be used to rinse the mouth for 1 minute and expectorated; immediately after, a sodium fluoride rinse, at a concentration of 0.05% (226 ppm of fluoride), will be used to rinse the mouth for 1 minute, and expectorated.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Livia M Tenuta, DDS, MS, PhD · Associate Professor, University of Michigan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-03-11
- Primary Completion
- 2021-04-05
- Completion
- 2021-04-05
Countries
- United States
Study Locations
More Related Trials
-
Oral Alkali Production and Caries Prevention in Children (Longitudinal)
NCT02398695 ·Status: COMPLETED
-
Beneficial Effects of Natural Products on Management of Xerostomia
NCT06217614 ·Status: COMPLETED ·Phase: NA
-
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
NCT06984848 ·Status: RECRUITING ·Phase: NA
-
Effect of Wearing Face Masks on Salivary Parameters and Halitosis
NCT04914208 ·Status: COMPLETED ·Phase: NA
-
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
NCT03005041 ·Status: COMPLETED ·Phase: NA
-
Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
NCT01652001 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Natural Antibacterial Mouthwash on Taste, Salivary pH and Bacteria in High Caries Risk pt
NCT03623048 ·Status: UNKNOWN ·Phase: NA
-
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685 ·Status: COMPLETED
-
Factors Controlling the Formation of Salivary Films
NCT01167504 ·Status: COMPLETED
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
NCT02641912 ·Status: COMPLETED ·Phase: NA
-
Xerostomia in Patients With a Life-limiting Condition or Frailty
NCT05506137 ·Status: UNKNOWN ·Phase: PHASE3
-
"Hyaluronan" Formulation for Dry Mouth in Sleep Apnea Patients
NCT03295019 ·Status: UNKNOWN ·Phase: NA
-
Occurrence of Selected Vitamins in Saliva and Blood
NCT02592148 ·Status: COMPLETED
-
Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
NCT00003686 ·Status: TERMINATED ·Phase: PHASE3
-
Effectiveness of Aquamin® in Mitigating Halitosis
NCT05058638 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Swallowing Function, Oral Health, and Food Intake in Old Age
NCT02825927 ·Status: COMPLETED ·Phase: NA
-
Oral Care of Intubated Intensive Care Patient
NCT06258603 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
NCT01690052 ·Status: COMPLETED ·Phase: NA
-
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
NCT03530735 ·Status: UNKNOWN ·Phase: NA
-
Saliva and Dental Calculus in Handicapped People
NCT00495989 ·Status: COMPLETED ·Phase: NA
-
Effects of Denture-Related Stomatitis on Blood Pressure in Denture Wearers
NCT02166450 ·Status: UNKNOWN
-
Local Pilocarpine for Relieving Dry Mouth
NCT04195100 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
OGT Spray in the Management of Xerostomia in the Elderly
NCT00350350 ·Status: COMPLETED
-
New "in Vitro" Diagnostic Test for Oral Malodour
NCT01226251 ·Status: UNKNOWN
-
The Oral Symptom Assessment Scale in Older Patients With Frailty
NCT06286982 ·Status: COMPLETED